尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Raffin Thomas A., 董事. Officer active across 3 companies, notably Lumos Pharma, INC.. Cumulatively, 5 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €103k. History available since 20 May 2021. The latest transaction was filed on 12 June 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Thomas A. Raffin is a Director at Lumos Pharma, Inc. In this role, he participates in the governance of the company and strategic decision-making. Thomas brings expertise in management and business development, helping to guide growth initiatives. His commitment to integrity and efficiency is an asset to the board.